Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) FCF Margin (2017 - 2025)

Creative Medical Technology Holdings has reported FCF Margin over the past 9 years, most recently at 64585.13% for Q4 2025.

  • Quarterly FCF Margin rose 39940.0% to 64585.13% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 97607.42% through Dec 2025, down 4941385.0% year-over-year, with the annual reading at 97607.42% for FY2025, 4941385.0% down from the prior year.
  • FCF Margin was 64585.13% for Q4 2025 at Creative Medical Technology Holdings, down from 53051.17% in the prior quarter.
  • Over five years, FCF Margin peaked at 1587.82% in Q3 2022 and troughed at 64984.53% in Q4 2024.
  • The 5-year median for FCF Margin is 18837.0% (2024), against an average of 27095.56%.
  • Biggest five-year swings in FCF Margin: surged 232007bps in 2022 and later crashed -4385839bps in 2023.
  • Tracing CELZ's FCF Margin over 5 years: stood at 1714.05% in 2021, then tumbled by -1026bps to 19307.71% in 2022, then crashed by -227bps to 63166.1% in 2023, then fell by -3bps to 64984.53% in 2024, then rose by 1bps to 64585.13% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 64585.13%, 53051.17%, and 64984.53% for Q4 2025, Q1 2025, and Q4 2024 respectively.